Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This study was a single-center, open-label, investigator-initiated clinical trial (IIT) to
observe and investigate the clinical safety and efficacy of SZ011 in the treatment of
advanced triple-negative breast cancer.
Phase:
Early Phase 1
Details
Lead Sponsor:
First Affiliated Hospital of Shantou University Medical College